Rivastigmine in Alzheimer’s disease: Cognitive function and quality of life

@article{Annicchiarico2007RivastigmineIA,
  title={Rivastigmine in Alzheimer’s disease: Cognitive function and quality of life},
  author={Roberta Annicchiarico and Alessia Federici and Carla Pettenati and Carlo Caltagirone},
  journal={Therapeutics and Clinical Risk Management},
  year={2007},
  volume={3},
  pages={1113 - 1123}
}
Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by a progressive loss of cognitive and functional abilities associated with various behavioral disturbances. Its impact on public health and society as a whole is devastating. Slowing of the cognitive impairment, and improvements in disease duration, self-sufficiency and behavioral disturbances represent the best outcomes of pharmacologic therapy. Cholinesterase inhibitors (ChE-I) have been shown to be effective in… CONTINUE READING